Test 4 Flashcards

1
Q

Heart Pathway

A

Superior vena cava > right atrium > tricuspid valve > right ventricle > pulmonary valve > pulmonary artery > lungs > pulmonary veins > left atrium > mitral valve > left ventricle > aortic valve > aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Current Cardiac Regenerative Therapies

A

1) Multipotent stem cells
2) Pluripotent stem cells
3) Non-cell strategies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cardiac Multipotent Stem Cells

A

Benefits: vascularization, immunoprivileged, improved cardiac function

Limitations: low cardiomyogenic potential, poor cell engraftment, limited proliferation potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiac Pluripotent Stem Cells

A

Benefits: high cardiomyogenic potential, good cell engraftment, unlimited proliferation

Limitations: slow, electrical instability, teratoma formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cardiac Non-Cell Strategies

A
  • Stimulation of endogenous cardiac repair (growth factors)
  • Direct reprogramming of fibroblasts into functional cardiomyocytes
  • Tissue Engineering
  • Exosomes derived from stem cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Main Targets for Tissue Engineering in Heart

A

1) Blood vessels
2) Heart muscle - myocardium
3) Heart valves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 Potential Cardiac TE Cells

A

1) Multipotent Adult Germline Stem Cells
2) Endothelial Progenitor Stem Cells
3) Very Small Embryonic-like Stem Cells
4) Endogenous Cardiac Stem Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

FGF Biomolecule

A

-promotes proliferation and differentiation

of endothelial cells, smooth muscle cells, fibroblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ang1, Ang2 Biomolecules

A

-stabilize blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PDGF, PDGFR Biomolecules

A

-recruit smooth muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

VE-Cadherin, CD31 Biomolecule

A

-promote endothelial junction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ehprin Biomolecule

A

-formation of veins and arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Plasminogen activator inhibit -1 Biomolecule

A

-stabilizes nearby vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TE Product Requirements: Biocompatibility

A
  • Minimize inflammatory/immunological response
  • Growth and healing capabilities
  • Tissue strength, stiffness, cellularity, composition, should be simillar to native tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TE Product Requirements: Functionality

A
  • Appropriate mechanical and hemodynamic functionality

- Must be durable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TE Product Requirements: Blood Vessels

A

-Must be able to withstand high-pressure fluid

dynamics, turbulence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

TE Product Requirements: Valves

A

-Must be able to operate in a very dynamic and severe
environment
-Open and close at 1 Hz, exposed to
mechanical stresses, high-pressure fluid dynamics,
turbulence, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

TE Product Requirements: Myocardium Patch

A
  • High vascularity is critical

- Mechanical and electrical anisotropy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

3 Cardiac Biomaterials

A

1) Biodegradable polymers (PGA)
2) Hydrogels (collagen, fibrin, alginate)
3) Decellularized tissue (collagen, elastin, fibronecting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Valve Replacement

A

1) Valves have complex architecture
2) TEHVs require complex molds
3) Cellularize with myofibroblasts to obtain a
functional valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

4 Limitations of Mechanical valves

A

1) Infections
2) Thromboembolism
3) Cannot grow
4) No self-repair capability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Limitation of Tissue-Engineered Valves

A

-Calcification of tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

3 Main Approaches to Biological Heart Valves

A

1) Cell seeding of biodegradable valve matrices
2) Cell seeding of decellularized allograft or xenograft valves
3) Promote repopulation and adaptive remodeling of decellularized allograft valves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Bypass Vascular Grafts

A
  • Walls cellularized with smooth muscle cells
  • Lumen cellularized with endothelial cells
  • Typical use is for coronary bypass surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Arteries and Veins

A

-Arteries carry oxygenated blood from the heart to the body (expect the
pulmonary artery)
-Veins carry deoxygenated blood used by the body back to the heart (except the pulmonary vein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Myocardium Patch

A
  • Tissue-engineered cardiac patches can be used to treat acute myocardial infarction
  • Augment contractile function
  • Promote revascularization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Myocardial Infarction

A
  • Heart Attack

- Decrease in oxygen supply to part of heart, causes necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Cell-Based cardiac pump

A
  • Hollow structure with cardiac cells
  • Contract in sync with host heart
  • Proposed for chronic heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Emphysema

A

Gradual damage of lung tissue, specifically thinning and destruction of the alveoli or air sacs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Lung Transplant Patient Survival

A

-Survival depends on many factors, including the
pre-transplant diagnosis, recipient age, weight
and overall health, type of transplant, various
donor characteristics and other factors.
-90% of those who pass away from complications from their lung transplant do so because
of acute cellular rejections.
-In first year, bacterial infection leading cause of mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Three Eye Layers

A

1) Sclera - fibrous tunic
2) Choroid - vascular tunic
3) Retina - nervous tunic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Retina

A
  • Sensory layer, innermost
  • Contains photoreceptors
  • Fovea centralis (macula lutae): center of retina, sharpest vision
  • Blind spot where optic nerve leaves the eye
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Rods

A
  • Ability to see grey tones
  • Sensitive to light
  • Excited in dim light
  • Provide peripheral vision
  • LOW RES
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Cones

A
  • Found in central areas
  • Need bright light to be excited
  • 3 types respond to either green, red, blue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Vitreous chamber

A
  • Posterior segment
  • Large chamber behind lens
  • Filled with clear gel: vitreous humor
  • Transmits light
  • Supports back of lens
  • Holds layers of retina in place
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Anterior chamber

A

•Smaller chamber between lens and cornea
• Filled with aqueous humor
• Nourishes lens and cornea (90 minutes!)
• Focuses incoming light
• Held in place by ligaments attached to ciliary
body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Choroid Coat

A
  • Vascular, nutritive layer
  • Contains melanin (prevents light from scattering inside the eye)
  • Anterior portion contains ciliary body and iris
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Ciliary body

A
  • Processes that secrete aqueous humor

- Muscle changes shape of lens to adapt near/far vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Iris

A
  • Made of pigmented smooth muscle

- Controls size of the pupil by dilation and constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Sclera

A
  • Fibrous tunic
  • Dense white fibrous connective tissue
  • Contains sclera, cornea, conjunctiva
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Sclera

A
  • White of the eye
  • Gives eye shape
  • Protects inside of eye
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Cornea

A
  • Transparent epithelium protects front of eye

- Where light enters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Conjunctiva

A

Clear mucous membrane that covers sclera

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Lens

A
  • Posterior to pupil and iris
  • Avascular transparent structure
  • Consists of crystallin protein arranged in layers
  • Attaches to ciliary body by ligaments that fine tune focusing of light on retina
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Eye Protection

A
  • Eyebrows
  • Eyelids
  • Eyelashes
  • Conjunctiva
  • Meibomian glands (oily lubricant)
  • Lacrimal apparatus (tears, antibodies and antibacterial agents)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Refraction

A
  • Both cornea and lens refract light rays

- To focus light, lens must change shape

47
Q

Myopia

A
  • Nearsightedness
  • Only close objects can be seen
  • Requires concave (negative) lenses
  • Light rays focused in front of retina
48
Q

Hyperopia

A
  • Farsightedness
  • Only distant objects can be seen clearly
  • Convex (positive) leens
  • Light rays focused behind retina
49
Q

Astigmatism

A
  • Two focal planes

- Horizontal and vertical light rays have different focal points

50
Q

Retinal Detachment

A

-As we age, shrinkage of the vitreous body (humor) may lead to a detachment of the
retina from the choroid
-A retinal detachment is considered a medical emergency and needs immediate repair
before vision loss becomes permanent

51
Q

Macular Degeneration

A
  • Loss of vision in the center of the visual field (the macula)
  • Damage to retina
  • Major cause for visual impairment in older adults
  • Impossible to recognize faces
52
Q

Cataracts

A
  • Opaque defect in cornea or lens

- Caused by injury, medication, diabetes

53
Q

Conjunctivitis

A
  • Inflammation of the conjunctival membrane, covers part of anterior eye
  • Caused most frequently by viral infections (pink eye) and allergy.
  • Also result from bacterial infections and many other irritants
54
Q

Glaucoma

A
  • Blockage to aqueous humor flow
  • Increase of pressure inside eye
  • Can lead to degeneration of eye function
55
Q

Diabetic retinopathy

A
  • most common cause of vision loss among people with diabetes
  • swelling of macula
56
Q

Cornea Tissue Engineering

A

Cells: mucosal epithelial cells, limbal stem cells

Tissues: amniotic membrane

57
Q

Lens Tissue Engineering

A

Currently, cataracts removed surgically and replaced with artificial intraocular lense

58
Q

PCO

A

-Posterior capsule opacification
-lens epithelial cells remaining after cataract
surgery have grown on the capsule causing it to
become hazy and opaque

59
Q

Retina Tissue Engineering

A

Cells: retinal pigment epithelium, ESC, iPSC
Biomaterial: thinner than 50 um, porous, biodegradable, correct Young’s modulus

Biomaterial Examples: PLGA, PLLA, PGS, PCL

60
Q

Two Approaches for Bionic Eye

A

1) Artificial Silicon Retina - ASR

2) Multi-unit Artificial Retina Chipset

61
Q

ASR

A
  • Artificial Silicon Retina
  • Microscopic silicon chip
  • Contains solar cells called microphotodiodes
  • Convert light energy from images into electrical impulses
  • Powered solely by incident light
62
Q

MARC

A
  • Multi-unit Artificial retina chipset

- uses CCD camera input and laser beam to transmit image into chip present in retina

63
Q

Neuroglia in PNS

A

Satellite cells:

  • surround neuron cell bodies
  • Regulate O2 and Co2 nutrient and neurotransmitter levels

Schwann cells:

  • surround axons, myelination of axon
  • Participate in repair process after injury
64
Q

Neuroglia in CNS

A

Oligodendrocytes:
-myelinate CNS axxons

Astrocytes:
-Maintain blood-barrier

Microglia:
-remove cell waste

Ependymal cells:

  • line ventricals/spinal cord
  • make cerebrospinal fluid
65
Q

Dendrites

A

Conduct impulses towards the cell body

66
Q

Soma

A

Control center of neuron

67
Q

Axon

A
  • Conduct impulses away from cell body
  • Only one axon per neuron
  • Trigger zone: site where action potentials are generated
68
Q

Sensory neurons

A
  • afferent = conduct signals to CNS

- specialize to detect stimuli

69
Q

Interneurons

A
  • within CNS

- interconnect incoming sensory pathways to outgoing motor pathways

70
Q

Motor neurons

A

-efferent = from CNS to muscles/effectors

71
Q

Myelination in CNS

A
  • By oligodendrocytes (myelinate multiple axons)
  • Myelin sheath: insulating layer around a nerve fiber
  • Newer layers of myelin must be pushed under the older ones
72
Q

Myelination in PNS

A
  • By Schwann cell (myelinate only one axon)

- Assists in nerve fiber regeneration

73
Q

White Matter

A
  • Aggregation of myelinated axons from many neurons

- Brain and spinal cord

74
Q

Grey Matter

A
  • Lacks myelin

- Formed from neuronal cell bodies and dendrites

75
Q

PNS Division

A
  • Somatic
  • Autonomic
  • Enteric
76
Q

Cranial Nerves

A
  • On: olfactory
  • Old: optic
  • Olympus: oculomotor
  • Towering: trochlear
  • Top: trigeminal
  • A: abducens
  • Fin: facial
  • And: auditory
  • German: glossopharyngeal
  • Viewed: vagus
  • Some: skeletal/accessory
  • Hop” hypoglossal
77
Q

Spinal Nerves (PNS)

A

-31 pairs of left-right spinal nerves

78
Q

Rate of nerve signal travel depends on 2 factors

A

1) Fiber diameter

2) Presence or absence of myelin

79
Q

Graded (Local) potential

A
  • Used for short-distance communication only
  • Do not travel down axon
  • Depolarize the cell
80
Q

Action potential

A
  • Allow for communication over long distances within the body
  • Requires threshold stimulus to fire
  • Trigger zone is where action potential is generated
81
Q

Resting membrane potential

A
  • Created using ion gradients and a variety of ion channels
  • Creates net negative charge inside cell
  • 70 mV
82
Q

Action Potential Graph

A

1) Local potential rises: Na+ ion arrive at axon hillock, depolarizing membrane
2) Threshold: potential reaches -55 mV, voltage-gated Na+ channels open
3) Neuron fires: membrane depolarizes, producing a spike as it passes past 0 mV, K+ gates slowly open
4) Peak: usually around +35 mVV
5) Repolarization K+ leaves neuron to drop membrane back to RMP
6) Hyperpolarization: K+ gates stay open long enough to drop 1-2 mV below RMP
7) Return to RMP

83
Q

Local Potentials vs Action Potentials

A

Local Potential: reversible, decremental, graded

Action Potential: irreversible, nondecremental, not graded

84
Q

Synaptic Transmission

A
  • action potential causes voltage-gated Ca 2+ channel to open in synaptic end bulb
  • Causes a release of neurotransmitter across synaptic cleft to bind to postsynaptic ligand-gated channels
85
Q

Regeneration of PNS Nerve Fiber

A

Can occur if:

  • neuron soma is intact
  • some neurolemma of Schwann cell remains
  • Nerve growth factors
86
Q

Steps of PNS Nerve Fiber Regeneration

A

1) Fiber is cut: macrophages clean up debris
2) Degeneration of schwann cell and axon
3) Regeneration: form regeneration tube, require NGFs
4) Regenerated fiber: fiber contacts target, soma shrinks to its original size

87
Q

Engineered Nervous Tissue Cells: Schwann Cells

A
  • Autologous Schwann Cells difficult to obtain in large numbers
  • Allogeneic Schwann Cells involved in immunological rejections
88
Q

Engineered Nervous Tissue Cells: Neural Crest Related Precursors

A

– From skin

– Differentiate into neurons and Schwann cells

89
Q

Engineered Nervous Tissue Cells: Embryonic Stem cells

A

-Grown in spheroid

90
Q

Engineered Nervous Tissue Cells: BMSCs, ASCs, iPS

A

-Differentiate into Schwann Cells

91
Q

Engineered Nervous Tissue Biomaterials: Decellularized

A

– Autologous non-neural
– Allogeneic neural / non-neural
– Xenogeneic neural / non-neural

92
Q

Engineered Nervous Tissue Biomaterials: Naturally derived polymers

A

– ECM proteins: collagen, laminin, fibrin, fibronectin, hyaluronan
– Polysaccharides: chitosan, alginate, agarose
– Proteins: silk, keratin
– FDA approved: NeuroGen
– CFDA (China’s FDA) approved: Chitosan based TENG

93
Q

Engineered Nervous Tissue Biomaterials: Biodegradable Synthetic polymers

A

– poly(phospoesters), polyurethanes, electrically conducting polymers
– FDA / CE (European) commerically available:
• Neurotube: PGA
• Neurolac: PLC

94
Q

Engineered Nervous Tissue Biological Factors: Growth Factors

A

– Nerve Growth Factor (NGF)
– Brain-Derived Neurotrophic Factor (BDNF)
– Neurotrophin-3 (NT-3)
– Glial Derived Neurotrophic Factor (GDNF)
– Ciliary Neurotrophic Factor (CNTF)
– Fibroblast Growth Factors (FGF)

95
Q

Engineered Nervous Tissue Biological Factors: Growth Factors Release

A

– Adsorption of growth factors into scaffold during fabrication
– Entrapment of growth factor-loaded microspheres into scaffold
– Immobilization of factors onto scaffold
– Installation of osmotic mini-pump or injection device
– Gene Therapy

96
Q

Engineered Nervous Tissue Electrical Factors: Electrical charges

A

-Stimulate cellular differentiation
– Neurite extension
– polyaniline, polypyrrole, polythiophene, and polyacetylene
– Graphene

97
Q

Tay-Sachs Diseasee

A
  • Degenerative disorder of the Myelin Sheath
  • Hereditary disorder of infants of Eastern European Jewish ancestry
  • Abnormal accumulation of glycolipid GM2 in myelin sheath disrupts conduction of nerve signals
98
Q

Multiple Sclerosis

A
  • Degenerative disorder of the Myelin Sheath
  • Oligodendrocytes & myelin sheaths in the CNS deteriorate
  • Myelin replaced by hardened scar tissue
  • “Immue-mediated”
99
Q

Amyotrophic Lateral Sclerosis

A
  • Neruodegenerative Disease

- Nerve cells break down, which reduces functionality in the muscles they supply

100
Q

Alzheimer’s Disease

A

-Neurodegenerative Disease
-Memory loss for recent events, moody, combative, lose ability to talk, walk & eat
-Show deficiencies of ACh & NGF
-Neurofibrillay tangles (microtubules): insoluble
twisted fibers found inside the brain’s nerve
cells. Cannot transport nutrients
-Formation of β-amyloid protein from breakdown product of PMs

101
Q

Parkinson Disease

A
  • Degeneration of dopamine-releasing neurons

- Progressive loss of motor function beginning in 50s or 60s: No recovery

102
Q

Tissue Engineering for Neurodegenerative Diseases

A
  • Blood Brain barrier model
  • Drug Toxicity/Disease Modeling
  • Neurodegeneration Model
  • Neuromuscular Junction Model
  • 3D Printed Nervous System on a chip
103
Q

Brain Tumors

A

Arise from:

  • Meninges
  • Metastasis from non-neuronal tumors in other organs
  • Glial cells (mitotically active)
104
Q

Spinal Cord Injury

A

1) Less/no sensation
2) Can’t sweat
3) Less body hair
4) Can’t cough (respiratory failure #1 cause of death among SCI patients)

105
Q

Scaffold Design for Nerve Repair

A
  • Nerve Guidance Conduit/Channel (NGC); cylindrical tube with empty lumen
    -After implantation, neural scaffold should act as a substrate for adhesion,
    proliferation, migration, and function of neural cells
106
Q

Biodegradable glass

A

repair facial / median

nerve in sheep

107
Q

ZnO ceramic

A

neural scaffold for PNS

regeneration

108
Q
Carbon nanostructures (nanotubes,
nanofibers, graphene)
A

used as guides

109
Q

Al2O3 nanostructures:

A

biocompatibility with

neural cells

110
Q

Natural Materials for nerve repair

A

-PGA,PLA,PLGA -processed into foams and seeded
with Schwann cells
- cross-linked PEG hydrogels + growth factors to mimic
the ECM are under development

111
Q

Advanced Therapies for Nerve Repair

A

-PLGA- Collagen conduits filled with collagen
fibres showed 80mm nerve defects to be treated in dogs.
-Not well controlled because of handmade
fabrication techniques and no scale up possible.

112
Q

Ink-Jet printing of polymers

A
  • -Precise delivery of polymer solutions.

- 3D structures with desired thickness, dimensions, incorporation of biomolecules possible

113
Q

Nanostructures are the anwer

A

yes they are